<DOC>
	<DOCNO>NCT02427386</DOCNO>
	<brief_summary>Endometriosis chronic inflammatory disease cause pelvic pain difficult treat . In view , many patient seek assistance complementary alternative medicine , include homeopathic treatment . The absence evidence literature raise controversy effectiveness homeopathic treatment endometriosis . The aim randomize trial evaluate effectiveness dynamize estrogen compare placebo treatment chronic pelvic pain endometriosis .</brief_summary>
	<brief_title>Homeopathic Treatment Chronic Pelvic Pain Women With Endometriosis</brief_title>
	<detailed_description>This randomize , double-blind placebo control trial use individualised homeopathic medicine ( dynamized estrogen ) treat chronic pelvic pain endometriosis . Patients endometriosis , chronic pelvic pain set sign symptom similar estrogen adverse event recruit Sector Endometriosis Clinical Division Gynaecological Hospital das Clínicas Faculty Medicine University Sao Paulo . The selection process carry analysis medical chart self-completing structured questionnaire . Satisfied inclusion criterion , fifty patient randomly distribute receive dynamize estrogen placebo . The primary clinical outcome severity chronic pelvic pain . Statistical analysis intention-to-treat per protocol compare homeopathic drug placebo 24 week intervention .</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Pelvic Pain</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>primary inclusion criterion : age 18 45 ; diagnosis endometriosis ( endometrial ectopia ) confirm image test ( MRI TVUS ) laparoscopy ( biopsy ) ; chronic pelvic pain refractory conventional hormone treatment intensity ≥ 5 visual analog pain scale ( VASPain : 010 point ) ; secondary inclusion criterion : symptomatic individualization patient accord adverse event estrogen ( minimum syndrome maximum value ) . absence clinical laboratory diagnosis menopause premature ovarian failure</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Endometriosis</keyword>
	<keyword>Pelvic pain</keyword>
	<keyword>Homeopathy</keyword>
	<keyword>RCT</keyword>
</DOC>